Summit Therapeutics, Inc. (SMMT)
16.20
+1.60
(+10.96%)
USD |
NASDAQ |
Sep 03, 10:42
Summit Therapeutics Research and Development Expense (TTM) : 568.74M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 568.74M |
| March 31, 2026 | 619.03M |
| December 31, 2025 | 537.67M |
| September 30, 2025 | 441.78M |
| June 30, 2025 | 348.41M |
| March 31, 2025 | 171.19M |
| December 31, 2024 | 150.80M |
| September 30, 2024 | 124.20M |
| June 30, 2024 | 101.79M |
| March 31, 2024 | 80.45M |
| December 31, 2023 | 59.46M |
| September 30, 2023 | 39.83M |
| June 30, 2023 | 41.34M |
| March 31, 2023 | 40.66M |
| December 31, 2022 | 51.08M |
| September 30, 2022 | 68.77M |
| June 30, 2022 | 71.63M |
| March 31, 2022 | 86.52M |
| December 31, 2021 | 84.34M |
| September 30, 2021 | 73.32M |
| June 30, 2021 | 67.05M |
| March 31, 2021 | 56.64M |
| Date | Value |
|---|---|
| December 31, 2020 | 50.71M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | 51.12M |
| October 31, 2018 | 52.36M |
| July 31, 2018 | 51.75M |
| April 30, 2018 | 47.44M |
| January 31, 2018 | 37.78M |
| October 31, 2017 | 30.52M |
| July 31, 2017 | 25.84M |
| April 30, 2017 | 24.84M |
| January 31, 2017 | 25.42M |
| October 31, 2016 | 26.88M |
| July 31, 2016 | 28.74M |
| April 30, 2016 | 27.77M |
| January 31, 2016 | 25.62M |
| October 31, 2015 | 22.51M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NovelStem International Corp. | -- |
| Brainstorm Cell Therapeutics, Inc. | 3.297M |
| Kezar Life Sciences, Inc. | 23.12M |
| Protara Therapeutics, Inc. | 52.89M |
| Clene, Inc. | 11.48M |